Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Combining cell biology with population-based studies to investigate the role of BCL-3 in therapeutic resistance to improve the treatment of rectal cancer


   School of Cellular and Molecular Medicine

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Prof A C Williams  No more applications being accepted  Funded PhD Project (European/UK Students Only)

About the Project

We are looking to recruit an enthusiastic and talented PhD student to work under the supervision of Professor Ann Williams in the School of Cellular and Molecular Medicine and with Professor Caroline Relton in the Bristol Medical School (PHS).

Background
The management of rectal tumours has improved significantly with combined use of surgical total mesorectal excision and pre-operative chemo-radiotherapy (CRT), however the reason why some patients respond better to CRT than others remains unknown (response ranges from no response to complete therapeutic response). Hence there is an urgent need, not only to improve the long-term response to existing therapies but also to detect patients who will most benefit from neoadjuvant CRT.

The project
Recent studies in stem cell biology have begun to identify the mechanisms underpinning the drive towards a more cancer stem cell (CSC)-like phenotype that contributes to therapeutic resistance and ultimately poor prognosis. Based on novel observations from the laboratory, this project focuses on the role of the newly identified BCL-3/β-catenin complex in colorectal tumour progression and therapeutic resistance. The approach combines proteomic analysis of 3D human rectal tumour models with complementary population-based causal analysis approaches including Mendelian randomization.

The successful candidate will be trained in the use of cutting edge molecular and cellular techniques and population health science research. They should have some experience in cancer biology and/or epidemiology, and a willingness to embrace this multi-disciplinary project.

Candidate requirements
Applicants should have, or expect to achieve, at least an upper second class honours degree (or equivalent) and / or with a research Masters degree in a relevant discipline (e.g. cancer biology, molecular biology, biomedical sciences).

Interested and suitably qualified candidates should make informal contact at with Professor Ann Williams ([Email Address Removed]) before 17 March 2018. The intended start date for the project is September 2018, but there is flexibility.

How to apply
Please make an online application for this project at http://www.bris.ac.uk/pg-howtoapply. Please select Cellular and Molecular Medicine PhD on the Programme Choice page. You will be prompted to enter details of the studentship in the Funding and Research Details sections of the form. For general enquiries linked to the online application process, please email [Email Address Removed].


Funding Notes

This studentship is funded by Bowel & Cancer Research and covers full UK/EU PhD tuition fees and a tax-free stipend at the RCUK rate (currently £14,553 per annum for 2017-18).

Where will I study?